In the context of leukemia, MZF1 was found to inhibit the differentiation of hematopoietic stem cells by suppressing the activity of the CD34 or c-myb promoters, thereby impeding differentiation and facilitating the emergence of a leukemia-like phenotype (15). Here, CD34 is linked to leukemia.